Tell us who you want to see featured on the list – and why, using the link below. We are counting on you to nominate your collaborators, colleagues and peers.
How will the adoption of novel approaches to the development of excipients help overcome the challenges of poorly soluble APIs?
How will inhaled therapies evolve? Lei Mao at Recipharm gives his take on the future of these therapies.
"Moving beyond Cas9 may be the secret to reducing CRISPR’s off-target effects," says Garrett Rettig.
Soon Jae Park
We must never forget unmet needs when developing new medicines.
Meet two companies that are advancing pharmaceutical development and manufacture.
Can new tools lower the hurdle of high manufacturing costs for cell and gene therapies?
After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.
Philip W. Wills
Now that Gene therapy's promise has been shown, the industry must focus on improving the manufacturing process and bring down costs.
Free “virtual assistant” tools offer a starting point for formulation – and easier access to regulatory documentation and other enabling information.
Don't forget to nominate the industry's most talented for our 2020 Power List!
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.